Caution is advised for patients with a history of pancreatitis, gallbladder disease, kidney disease, diabetic retinopathy, or gastrointestinal motility disorders
Most are available as subcutaneous injections administered once weekly or daily, while semaglutide (Rybelsus) is also available as an oral tablet
An integrative multiomics approach to characterize prebiotic inulin effects on faecalibacterium prausnitzii
Brain Res 1678:123128
This article explores early warning Read More Incretin Therapy Selection in High-Risk Patients: What New Outcomes Data Suggest May 4, 2026 Articles, Cardiology, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 876 views Choosing the right treatment for patients with both diabetes and heart disease can feel like walking a tightrope